PharmaVoice 100: Page 7
-
Diego Camargo/PharmaVoice
Podcast
Woman of the Week: Daré Bioscience’s Sabrina Martucci Johnson
The CEO is setting a path to transform women’s health at an opportune time.
By Taren Grom • March 30, 2022 -
Diego Camargo/PharmaVoice
Podcast
Woman of the Week: Genentech’s Quita Highsmith
Quita Highsmith is changing how Genentech approaches diversity and inclusion across the board — from drug development to career advancement.
By Taren Grom • March 9, 2022 -
Permission granted by Ramona Sequeira.
Q&ARamona Sequeira breaks PhRMA’s glass ceiling
A few weeks ago, PhRMA, the industry’s largest trade group, announced that Sequeira has officially become chair of the organization’s board of directors. She is the first woman — and first woman of color — to take on the job.
By Taren Grom • March 7, 2022 -
Diego Camargo/PharmaVoice
Podcast
Woman of the Week: Lyndra Therapeutics’ CEO Dr. Trish Hurter
With Lyndra’s ultra-long-acting therapies, Hurter and the company are aiming to reinvent medicines.
By Taren Grom • March 2, 2022 -
Diego Camargo/PharmaVoice
The 2022 PharmaVoice 100 — new look, same drive for excellence
Some of the industry’s biggest names have been on our list of honorees. Now it’s time to find this year’s inspiring leaders.
By Taren Grom • Feb. 28, 2022 -
Stock via Getty Images
Q&ACandel’s CEO looks to help ignite a new era of cancer treatments
Candel Therapeutics is advancing a next-gen approach in oncology: using viruses to kill cancer cells at the site of injection.
By Taren Grom • Feb. 28, 2022 -
Permission granted by Guadalupe Hayes-Mota
ProfileGuadalupe Hayes-Mota’s ‘recipe’ for tackling pharma’s supply chain issues
A quest to expand access to medical treatment globally led to a new career path when Guadalupe Hayes-Mota left his biotech leadership roles to start his own company.
By Robin Robinson • Feb. 25, 2022 -
Diego Camargo/PharmaVoice
Podcast
Woman of the Week: Sumitovant’s Chief Business Development and Commercial Officer Adele Gulfo
Adele Gulfo, chief business development and commercial officer at Sumitovant Biopharma, is leaning into her decades of experience to bring a future-focused approach to drug development.
By Taren Grom • Feb. 23, 2022 -
Courtesy of Saniona
Q&ASaniona’s CEO on why it takes a village to develop treatments for a rare disease
Saniona built its village by first hiring a head of patient advocacy.
By Kim Ribbink • Feb. 8, 2022 -
Courtesy of Ferring Pharma
Ferring Pharmaceuticals president discusses the need for more funding in women’s health research
Read why women’s healthcare funding is such a challenge.
By Robin Robinson • Feb. 4, 2022 -
Retrieved from Google image.
OpinionIndustry executives predict the next ‘blue oceans’ in pharma
Where life science leaders see breakthroughs happening in the industry.
By Taren Grom • Feb. 4, 2022 -
Permission granted by Mary Harmon
Q&APTC’s vice president of patient relations outlines the importance of patient input in rare disease R&D
You can’t know what matters to rare disease patients unless you ask them.
By Kim Ribbink • Feb. 3, 2022 -
Permission granted by Peter Anastasiou
Q&A // First 90 DaysNew Capsida Biotherapeutics CEO Peter Anastasiou aims to bring AAV therapy to reality
Read what Capsida CEO Peter Anastasiou has planned for his new role.
By Taren Grom • Feb. 3, 2022 -
Diego Camargo/PharmaVoice
Podcast
Woman of the Week: Google Cloud’s Andrea McGonigle
Andrea McGonigle, Google Cloud’s general manager, healthcare and life sciences partnerships and strategic initiatives, is intent on bringing technology and innovation together to solve some of the biggest challenges in healthcare.
By Taren Grom • Feb. 2, 2022 -
Pekic via Getty Images
OpinionTalent acquisition stays top of mind for pharma execs
From creating flexible work environments to looking outside the industry for new talent, pharma execs are shifting strategies to keep their teams afloat.
By Taren Grom • Feb. 1, 2022 -
Retrieved from Rare Disease.org.
Q&AFor the CEO of Travere, running a rare disease company is personal
To kick off Rare Disease month, we interview the CEO of Travere Therapeutics
By Kim Ribbink • Feb. 1, 2022 -
Q&A
Foghorn’s CEO on why collaborations are key to unlocking precision medicine
With a major development deal under his belt, Adrian Gottschalk is helping the company advance its innovative platform.
By Robin Robinson • Jan. 28, 2022 -
Retrieved from Google image.
ProfileEvofem CEO Saundra Pelletier aims to level the playing field between men’s and women’s health
Evofem CEO and PharmaVoice100, Saundra Pelletier, discusses funding challenges for women’s health.
By Alexandra Pecci • Jan. 23, 2022 -
Permission granted by Copyright: <a href=‘https://www.123rf.com/profile_ileezhun’>ileezhun</a>
Biote CEO breaks down barriers in women’s health
Women’s health is coming into sharper focus in 2022, but getting funding is still difficult.
By Robin Robinson • Jan. 11, 2022 -
[photo]. Retrieved from Ovid Therapeutics.
Q&AOvid’s CEO shares his vision for rare disease developments
Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.
By Kim Ribbink • Jan. 10, 2022 -
Justin Sullivan/ via Getty Images
Q&AHow the executive VP of HR at Incyte is tackling pharma’s hiring woes
In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.
By Meagan Parrish • Jan. 10, 2022 -
Shaun Lucas/PharmaVoice
Red Jacket honorees 2022The Red Jacket awards
The PharmaVoice 100 ‘hall of fame’ winners
By Megan McCoskey • Dec. 22, 2021 -
Diego Camargo/PharmaVoice
Submit pitches for PharmaVoice’s ongoing series
Our new approach to recognizing inspiring leaders across the industry.
By The PharmaVoice Team • Dec. 17, 2021 -
PharmaVoice Team/PharmaVoice
ProfilePharmaVoice 100 Who’s on the List – By Category
Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...
By PharmaVoice Team • Aug. 1, 2021 -
PharmaVoice Team/PharmaVoice
Profile
Commanders & Chiefs
These forward-thinking leaders are inspiring their teams to achieve far-reaching goals and strategically positioning their companies for success as they navigate complex industry challenges. Be bold Igniting change by… Addressing barriers between patients and their medicines Vict...
By PharmaVoice Team • Aug. 1, 2021
Previous
To find more content, use the “Topics” in the menu above.
